JNCCN 360

Editor:

James L. Mohler, MD

Advertisement

Advertisement

Karim Fizazi, MD, PhD, on Darolutamide Treatment in Prostate Cancer: Helping Patients Assess Benefits vs Risks

Michael J. Morris, MD, on the Alliance Trial: Clinical Implications of Combination Therapy for Prostate Cancer

Kim N. Chi, MD, on Adding Apalutamide to Androgen-Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer

Recent

Comparing Biopsy Methods in Detecting Prostate Cancer

Targeted Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer

Initiative to Reduce Narcotic Prescribing in Robotic Radical Prostatectomy

Interim Scan During Radioligand Therapy for Men With Advanced Prostate Cancer

Published

Medical Literature

Inguinal Hernia After Minimally Invasive Radical Prostatectomy

Abiraterone Acetate and Prednisone Plus ADT: Final Survival Data From LATITUDE Trial

Radiotherapy After Prostatectomy: Updated Joint Clinical Guidance by ASTRO and AUA

Adding Docetaxel to Standard Treatment in High-Risk Prostate Cancer

Ongoing

Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Systemic Treatment of Prostate Cancer

Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care – Prostate Cancer

Current Approaches to the Treatment of Metastatic Castration-Resistant Prostate Cancer

Available

Clinical Trials

MD Anderson Cancer Center

The University of Alabama at Birmingham Comprehensive Cancer Center

Massachusetts General Hospital Cancer Center

Duke Cancer Institute

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.